What other stocks do shareholders of PolyNovo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PolyNovo investors own include Immutep (IMMP) , Rural Funds Group (RFF) , Vanguard FTSE Pacific ETF (VPL) , UQM Technologies (UQM) , Tesla (TSLA) , Starpharma (SPL) , Moelis Australia (MOE) , iSignthis (ISX) , Align Technology (ALGN) and Acasti Pharma (ACST) .

ASX:PNV

PolyNovo (PNV) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free PNV Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 3.38 million shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 6.86%
Price Target: N/A

Stock Analysis

Get PolyNovo alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About PolyNovo Stock (ASX:PNV)

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

PNV Stock News Headlines

March 10, 2024 | msn.com

ImpediMed’s new leadership team looks to grow the company

March 8, 2024 | msn.com

Australia stocks higher at close of trade; S&P/ASX 200 up 1.07%

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 3, 2024 | msn.com

ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2

February 28, 2024 | fool.com.au

3 ASX 200 shares just scored significant broker upgrades. Here's how

February 23, 2024 | fool.com.au

Why the PolyNovo share price has rocketed almost 200% higher in 12 months

February 19, 2024 | msn.com

Fundie Merchant Group picks four biotech stocks that could rip as sector hits rude health again

February 1, 2024 | au.finance.yahoo.com

PolyNovo Limited (PNV.AX)

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

January 26, 2024 | msn.com

ScoPo’s Powerplays: Nanosonics ‘in the doghouse’, but ASX health stocks are largely being good boys

January 22, 2024 | fool.com.au

Up 10%: Why the Polynovo share price is popping today

January 22, 2024 | finance.yahoo.com

Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?

December 12, 2023 | fool.com.au

Why BlueScope, Fortescue, Polynovo, and Sigma shares are racing higher

December 5, 2023 | msn.com

16 top stocks inside these high-performing Aussie equities funds

November 21, 2023 | finance.yahoo.com

PolyNovo (ASX:PNV) shareholders have earned a 21% CAGR over the last five years

November 13, 2023 | reuters.com

Spain's Sanchez wins support for PM bid amid anger over Catalan amnesty vow

October 26, 2023 | finance.yahoo.com

Polynovo Ltd (MFJ.SG)

September 26, 2023 | morningstar.com.au

An undervalued opportunity among ASX shares added to our coverage

September 24, 2023 | fool.com.au

Polynovo shares jump 12% on 'breathtaking' sales growth

September 13, 2023 | fool.com.au

Trading near 52-week lows, are Polynovo shares too cheap to ignore?

July 15, 2023 | ca.finance.yahoo.com

PNV.AX - PolyNovo Limited

July 6, 2023 | msn.com

Australia stocks lower at close of trade; S&P/ASX 200 down 1.24%

June 14, 2023 | finance.yahoo.com

PolyNovo (ASX:PNV) pulls back 7.4% this week, but still delivers shareholders stellar 23% CAGR over 5 years

June 8, 2023 | msn.com

WILSONS Maintains PolyNovo (ASX:PNV) Underweight Recommendation

June 8, 2023 | msn.com

BELL POTTER SECURITIES Maintains PolyNovo (ASX:PNV) Buy Recommendation

June 7, 2023 | afr.com

PolyNovo surges as sales advance to record

June 6, 2023 | msn.com

Why is the Polynovo share price racing 14% higher today?

See More Headlines

Receive PNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyNovo and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: ASX:PNV
CUSIP: N/A
CIK: N/A
Web: www.polynovo.com.au
Phone: 61 3 8681 4050
Fax: N/A
Employees: 237
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: 2.63
Net Income: $1.59 million
Net Margins: 1.91%
Pretax Margin: N/A
Return on Equity: 2.42%
Return on Assets: -1.10%

Debt

Debt-to-Equity Ratio: 22.20
Current Ratio: 5.01
Quick Ratio: 1.58

Sales & Book Value

Annual Sales: $83.47 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 207.50
Book Value: A$0.10 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 690,230,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.65

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Swami Raote BPHARM
M.B.A., CEO & Director
Mr. Jan-Marcel Gielen C.A.
CFO & Company Secretary
Dr. David McQuillan Ph.D.
Chief Technical & Scientific Officer
Mr. Philip Scorgie
Chief Information Officer
Mr. Ahmed Hassan
Director of Operations
Ms. Teena Chadha
APAC Marketing & Distributor Manager
Ms. Monica Benyk
HR Manager
Dr. Tim Moore
Principal Scientist
Mr. Edward Graubart
Senior Vice President of Sales & Marketing (Americas)

Key Competitors

View All Competitors

Insiders

PNV Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of PolyNovo own?: Based on aggregate information from My MarketBeat watchlists, some companies that other PolyNovo investors own include Immutep (IMMP), Rural Funds Group (RFF), Vanguard FTSE Pacific ETF (VPL), UQM Technologies (UQM), Tesla (TSLA), Starpharma (SPL), Moelis Australia (MOE), iSignthis (ISX), Align Technology (ALGN) and Acasti Pharma (ACST).

This page (ASX:PNV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial